AID-OAA-TO-15-00007 GHSC-PSM TO1 extension Justification and Approval (J&A)

The contract modification extends the period of performance for Task Order AID-OAA-TO-15-00007 under the GHSC-PSM IDIQ contract with Chemonics International Inc. by 12 months, from November 29, 2026, to November 28, 2027, at no additional cost. This action is justified under the Expedited Procedures Package for PEPFAR, citing the need to ensure uninterrupted delivery of life-saving commodities—including antiretrovirals, tuberculosis treatments, and maternal and child health products—to more than 48 countries across 33 operating nations. The extension safeguards against supply chain disruptions and operational gaps during the transition to a new procurement mechanism, preserving critical program continuity and avoiding risks that could compromise public health outcomes. The total estimated value of the task order remains fixed at $7,560,230,299, funded primarily by HIV/AIDS appropriations, with the modification relying on AIDAR 706.302-70(b)(3)(ii) and FAR 6.303 to waive full and open competition due to the unacceptable risk of service interruption. Performance is centered in Arlington, Virginia, with administrative oversight from the Department of State’s Contracting Office in Washington, DC, and execution managed by a global team of approximately 900 personnel. The contracting officer, Ousay Wahaj, and the Contracting Officer’s Representative, Sherif Mowafy, oversee compliance, while legal oversight is provided by Diane Perone. Although no formal contract clauses, evaluation factors, pricing details, or inspection criteria are specified in the provided documentation, the justification emphasizes operational stability, existing contractor expertise, and seamless transition as the basis for sole-source award. The modification was approved on September 30, 2025, and posted on May 6, 2026, with the contractor expected to cease placing new orders by August 2025 while continuing deliveries through the extended period.